drugset / Trial / NCT01059539
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with bipolar I disorder.
Timeline
- Start
- 2010-02-28
- Primary completion
- 2012-02-29
- Completion
- 2012-02-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cariprazine | Small molecule | 3 mg | Oral |